请使用支持JavaScript的浏览器!
主营:高分子化学,分子和细胞生物学,转染试剂
℡ 4000-520-616
℡ 4000-520-616
Altogen/AsPC-1 Transfection Reagent (Pancreatic Beta Cells)/0.5 ml(Catalog #1709)
产品编号:0.5ml(Catalog#1709)
市  场 价:¥5360.00
场      地:美国(厂家直采)
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$268.00
品      牌: Altogen
公      司:Altogen Biosystems
公司分类:
Altogen/AsPC-1 Transfection Reagent (Pancreatic Beta Cells)/0.5 ml(Catalog #1709)
商品介绍

Description

ProductAvailABIlity:InStock(deliverywithin2-3businessdays,noextrachargefordrop-shipping).

Ordering:ToplaceanorderviacreditcardorPOuseAddtoCartbutton(creatinganaccountisnotrequired).


TransfectionReagentfor ASPC-1Cells(PancreaticBetaCells,CRL-1682)

  • Ananoparticle-basedliposomeformulation
  • Transfectionprotocolsprovidedfortransfectionofproteins,DNA,mRNA,siRNA,shRNAandmicroRNA
  • TransfectionEnhancerreagentprovidedwiththekit
  • Producehigherlevelofrecombinantproteinexpressionwithminimaldisruptionofnormalcellfunction
  • Generatephysiologicallyrelevantdatayoucantrust
  • EffectiveforplasmidDNA/siRNAco-transfection
  • Easy-to-usetransfectionprotocolwithreproducIBLeresults
  • Lowcytotoxicity
  • DownloadinvitroASPC-1transfectionprotocol:[PDF]
  • Download ASPC-1CRISPR/Cas9transfectionprotocol:[PDF]
  • DownloadPowerPointpresentationforASPC-1cellstransfectionkit:[PPT]
  • DevelopedandmanufacturedbyAltogenBiosystems

TransfectionEfficiency:

Reagentexhibitsatleast70%transfectionefficiencyofsiRNAdelivery.Transfectionefficiencywasdeterminedby qRT-PCR.

TransfectionProtocolandMSDS:

DownloadAltogenBiosystemsASPC-1TransfectionProtocol:[PDF]

DownloadMSDS:[PDF]

ASPC-1 CellLine:

Pancreaticcancerisoneofthemostchallengingcancerstodiagnose,astherenospecificandreliablescreeningtestsonthemarketthatcanhelpdetectthediseaseinearlystages.AccordingtotheAmericanCancerSociety,ifcaughtinitsearlystages,the5-yearsurvivalrateis27%,butifcancermetastasizesthenthisnumbergoesdownto11%.TheAsPC-1celllinecomprisingpancreaticbetacellsandisaninvaluabletoolforpancreaticcancerresearchaswellascommonlyemployedforstudyinghumaninfectionsrelatedtothepancreas.TheAsPC-1celllinewasreestablishedvianudemousexenograftsinitiatedwithcellsfromtheascitesofa62-year-oldCaucasianwomanwithmetastaticpancreaticadenocarcinoma.Thereestablishedepithelialcellsretainedtheiroriginalmorphology.Thistumorrepresentsanewmodelforhumanpancreaticcancer.AsPC-1cellsareusedinstudiesseekingpossibletreatmentsforpancreaticcancer,whichhasafive-yearsurvivalrateoflessthanonepercent.Forexamples,researchhasshownthattheplantalkaloidsanguinarineinducedapoptosisofAsPC-1cells.Inanotherstudy,immunoprecipitationandELISAusinghumanpancreaticcancercellsrevealedthepresenceofhighlevelsofDcR3proteininAsPC-1cells.ReducingendogenousDcR3levelsincreasesFasL-inducedapoptosisofhumanpancreaticcancercells.Anotherintriguingstudyindicatedthatdeuteriumoxide(D2O),alsocalledheavywater,inducedapoptosisofAsPC-1,andisconsideredapossiblefuturetreatmentagainstAsPC-1.

Data:

Figure1.CyclophilinBsilencingefficiencywasdeterminedbyqRT-PCRintheAsPC-1cellstransfectedbyCyclophilinBsiRNAornon-silencingsiRNAcontrolfollowingtherecommendedtransfectionprotocol.CyclophilinmRNAexpressionlevelsweremeasured48hourspost-transfection.18SrRNAlevelswereusedtonormalizetheCyclophilinBdata.Valuesarenormalizedtountreatedsample.Dataarepresentedasmeans±SD(n=3).

AsPC1-cells-transfection-protocol

Figure2.ProteinexpressionofCyclophilinBinAsPC-1cells.DNAplasmidexpressingCyclophilinBorsiRNAtargetingCyclophilinBweretransfectedintoAsPC-1cellsfollowingAltogenBiosystemstransfectionprotocol.At72hourspost-transfectionthecellswereanalyzedbyWesternBlotforproteinexpressionlevels(normalizedbytotalprotein,10µgoftotalproteinloadedpereachwell).Untreatedcellsusedasanegativecontrol.

Selected invivo transfectionproductcitations(ALTOGEN® INVIVO TransfectionKits usedinthefollowingpublications):

  • Nature.2008454(7203):523-7.Innateimmunityinducedbycomposition-dependentRIG-I…Saitoetal[PDF]
  • Am JPathology.2010177(4):1870-80.RoleofocularcomplementfactorHinamurinemodel…Lyzogubovetal[PDF]
  • NatureBiotechnology.201129(4):341-5.DeliveryofsiRNAtothemousebrainby…Alvarez-Ervitietal [PDF]
  • CancerResearch.201171(15):5144-53.InhibitionofmiR-193aexpressionby…Iliopoulosetal[PDF]
  • RNA.201016(11):2108-19.RNaseLreleasesasmallRNAfromHCVRNAthatrefolds…Malathietal[PDF]
  • Diabetologia.201255(7):2069-79.Thep47phox-andNADPHoxidaseorganiser1…Younetal [PDF]
  • BritishJournalofCancer.2012 107(3):516-26.TIGARinducesp53-mediatedcell-cycle…Madanetal[PDF]
  • Hypertension.201463(2):353-61.Tissuetransglutaminasecontributesto…Liuetal[PDF]
  • Circulation Research.201015;107(8).Kruppel-likefactor-4transcriptionallyregulates…Cowanetal[PDF]
  • Hypertension.201259(1):158-66.Roleofuncoupledendothelialnitricoxidesynthase…Gaoetal[PDF]
  • JounalofBIOLOGicalChemistry.2012287(4):2907.Chaperoningofmutantp53protein…Gognaetal [PDF]
  • PLoSPathogens.20128(8)Uridinecompositionofthepoly-U/UCtractofHCVRNA…Schnelletal[PDF]

RequestaQuotefor
AsPC-1TransfectionReagent

AltogenBiosystems:
AltogenBiosystemsprovidespreoptimizedtransfectionproductsforlifescienceresearchapplications.Transfectionprotocolsareoptimizedforindividualcancercelllines.AltogenBiosystemsdevelopedtwotypesofinvivodeliverykitsforanimalresearch:Tissue-targetedreagents(deliverytoliver,pancreas,andkidneytissues),andbroadrangeinvivodeliveryreagents(PEG-Liposome,Nanoparticle-based,Lipid-based,andPolymer-basedkits).Advancedformulationofreagentsandoptimizedtransfectionprotocolsprovideefficientintracellulardeliveryofproteins,DNA,RNA,andanyothernegativelychargedmoleculesinvitroandinvivo.Readmore abouttransfectiontechnologyatAltogen’sTransfectionResource.

AltogenLabsResearchServices:

AltogenLabsprovidesGLP-compliantcontractresearchstudiesforpre-clinicalresearch,INDapplications,anddrugdevelopment.BiologyCROservices include:Xenograftmodels(30+),developmentofstablecelllines,ELISAassaydevelopment,cell-basedandtissuetargetedRNAistudies,safetypharm/toxassays,andotherstudies(visitAltogenLabs.com).

VolumeOptions:

  • 0.5ml(Catalog#1709)
  • 1.5ml(Catalog#1710)
  • 1.5mlCRISPR(Catalog#2109)
  • 8.0ml(Catalog#7023)
品牌介绍


Altogen Biosystems是一家开发和制造用于生命科学研究,药物发现和开发的转染试剂盒的生物技术公司。转染试剂盒针对特定癌细胞系和原代细胞培养进行了优化,可将生物分子有效递送到靶组织中。通过先进的试剂配方和优化的转染方案实现体外(癌细胞系)和体内(动物组织靶向试剂癌细胞系)递送货物分子,包括质粒DNA,各种类型的RNAmRNAsiRNAshRNAmicroRNA),蛋白质和小分子研究。

苏州蚂蚁淘代理Altogen Biosystems在中国的业务。Altogen Biosystems北京代理,Altogen Biosystems华东代理Altogen Biosystems华北代理,Altogen Biosystems全国代理Altogen Biosystems华南代理

自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔